New York State Department of Health Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states. Grail Gets NY State Department of Health Approval for Galleri Multicancer Test Galleri is designed to detect more than 50 cancer types through a routine blood draw and, when a cancer signal is detected, predict its origin. Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions. Karius Receives NY State Approval for Infectious Disease Liquid Biopsy Test The permit covers the test for all five pathogen categories: bacteriology, mycobacteriology, mycology, parasitology, and virology. Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic The company's DecisionDx-SCC is meant to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors. May 11, 2021 Applied DNA Sciences Subsidiary Gets CLIA Certification From NY State Department of Health Apr 28, 2021 NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Feb 18, 2021 Rady Children’s Institute for Genomic Medicine Gets NY State Approval for Sequencing Tests Jan 11, 2021 NYS Department of Health Allows Clinical Genomics to Offer Colorectal Cancer Test Jun 12, 2020 RenalytixAI Receives Approval From New York State to Offer Kidney Test Jun 3, 2020 OpGen Expands Partnership With New York State Department of Health to Detect AMR Infections Mar 17, 2020 FDA Dramatically Expands Enforcement Discretion to Speed COVID-19 Test Access Mar 13, 2020 Responding to Coronavirus Test Shortage, FDA Lets NY State Health Department Authorize Assays Feb 11, 2020 New York State Approves Enzo Biochem STI Tests on GenFlex Platform Dec 16, 2019 Ambry Genetics Gains NYS Approval for Paired RNA, DNA Genetic Test Sep 24, 2019 Enzo Clinical Labs Gets NY State Approval for HBV Assay Aug 2, 2019 Fulgent Gets NY State Clinical Lab Permit, Approval to Offer Genetic Tests Jul 31, 2019 Adaptive Bio Receives NY State Approval for ClonoSeq in B Cell Cancers Jul 11, 2019 Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models Jun 21, 2019 Liquid Biopsy Assay From MSKCC Approved by New York State May 30, 2019 Columbia University Medical Center NGS Cancer Panel Receives New York State Conditional Approval May 22, 2019 PreludeDx Receives New York State Approval for DCIS Test Apr 23, 2019 Veracyte Secures NY State Approval for Genomic Classifier Test for Lung Disease Mar 28, 2019 Eurofins Subsidiary Gets New York State Approval for Addition of Y Chromosome Screen to NIPT Test Load More Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.